Related Experiment Video
Updated: Sep 19, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Morin Mitigates Methamphetamine-Induced Neurotoxicity: Effects on Motor and Cognitive Function
Godson E Anyanwu1,2, Amarachukwu Vivian Umeano3, Vivian O Ojiakor1,4
1Department of Anatomy, Faculty of Biomedical Sciences, Kampala International University, Kampala, Uganda.
Introduction:
Neurodegenerative diseases are a major public health concern, often associated with motor and cognitive deficits. Methamphetamine (METH) exposure induces lasting neurological impairment and neuronal loss. This study evaluated Morin's potential to reverse these effects, focusing on motor and cognitive dysfunction in METH-induced neurotoxicity.
Methods:
Adult rats were randomly assigned into seven groups, including control, Morin-only, METH-only, METH plus fluoxetine, and three groups receiving METH followed by varying doses of Morin. Following METH induction, Morin, a natural flavonoid with antioxidant properties, was administered to rats. Neurobehavioral tests evaluated motor and cognitive function; serum levels of oxidative stress markers, inflammatory cytokines, dopamine, and acetylcholine were measured. Histological and immunohistochemical analyses of the basal ganglia were performed to evaluate neuronal integrity.
Results:
METH exposure significantly elevated oxidative stress and inflammatory markers, altered neurotransmitter levels, and impaired both motor and cognitive performance, coinciding with neuronal loss in the basal ganglia. Treatment with Morin ameliorated these effects in a dose-dependent manner. Neuronal degenerative features noted in the METH-only group were significantly ameliorated in the Morin-treated groups.
Conclusion:
These findings indicate that Morin mitigates METH-induced neurotoxicity by reducing oxidative stress, and suppressing inflammation. This study demonstrates Morin's potential as a treatment option for the neurological effects of methamphetamine misuse.
Insights
Morin, a natural flavonoid, effectively reverses methamphetamine (METH)-induced neurotoxicity and improves motor and cognitive deficits in rats by reducing oxidative stress and inflammation.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Neurodegenerative diseases present significant public health challenges.
- Methamphetamine (METH) exposure causes persistent neurological damage, including neuronal loss and functional deficits.
- Identifying therapeutic agents to counteract METH-induced neurotoxicity is crucial.
Purpose of the Study:
- To investigate the neuroprotective potential of Morin against METH-induced neurotoxicity.
- To evaluate Morin's efficacy in reversing motor and cognitive impairments caused by METH.
- To explore the underlying mechanisms of Morin's action, including its effects on oxidative stress and inflammation.
Main Methods:
- Adult rats were exposed to METH and subsequently treated with varying doses of Morin or fluoxetine.
- Neurobehavioral tests assessed motor and cognitive functions.
- Biochemical assays measured oxidative stress markers, inflammatory cytokines, dopamine, and acetylcholine.
- Histological and immunohistochemical analyses examined neuronal integrity in the basal ganglia.
Main Results:
- METH exposure led to increased oxidative stress, inflammation, altered neurotransmitter levels, and impaired motor/cognitive functions, with associated neuronal loss.
- Morin administration dose-dependently ameliorated METH-induced neurobehavioral deficits and neuronal damage.
- Morin treatment significantly reduced oxidative stress and inflammatory markers in METH-exposed rats.
Conclusions:
- Morin demonstrates significant neuroprotective effects against METH-induced neurotoxicity.
- Morin mitigates METH-induced neurological damage by reducing oxidative stress and suppressing inflammation.
- Morin shows potential as a therapeutic agent for addressing the neurological consequences of methamphetamine misuse.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Neurochemical Transmission: Sites of Drug Action
CNS Depressants: Alcohol and Nicotine
Drugs Affecting Neurotransmitter Release or Uptake